Borel, A-L
Nazare, J-A
Smith, J
Aschner, P
Barter, P
Van Gaal, L
Eng Tan, C
Wittchen, H-U
Matsuzawa, Y
Kadowaki, T
Ross, R
Brulle-Wohlhueter, C
Alméras, N
Haffner, S M
Balkau, B
Després, J-P
,
Article History
Received: 17 March 2014
Revised: 8 July 2014
Accepted: 3 August 2014
First Online: 2 September 2014
Competing interests
: Jean-Pierre Després has received a research grant from Eli Lilly, has received speaker’s fees from Abbott, AstraZeneca, Merck, GlaxoSmithKline and Pfizer Canada Inc. and is on the consultant/advisory board of Novartis, Theratechnologies, Torrent Pharmaceuticals Ltd, Abbott and Sanofi. All the other authors declare no conflict of interest.